Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
for
Breast Cancer, Stage III Breast Cancer, Breast Cancer Female,
Location: Boston MA, State College PA, Pittsburgh PA,
Sponsor: Dana-Farber Cancer Institute
Sex: Female
Age: 65+
Code: NCT05535192
Recruiting
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
for
Major Depressive Disorder
Location: Farmington CT, Brooklyn NY, New York NY, Toms River NJ,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18 - 65
Code: NCT05850689
Phase 3, Recruiting
Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Minimally Invasive Surgery
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
for
Pancreatic Ductal Adenocarcinoma
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT07199764
Phase 2, Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
for
Head and Neck Squamous Cell Carcinoma (HNSCC),
Location: Richmond VA, Chapel Hill NC, Miami FL, Pittsburgh PA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06295731
Phase 2, Phase 3, Recruiting
Treatment Validation for Myofascial Pain
for
Chronic Low-back Pain (cLBP), Myofacial Pain
Location: Pittsburgh PA
Sponsor: Ajay Wasan, MD, Msc
Sex: All
Age: 20 - 70
Code: NCT07133139
Recruiting
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
for
Diabetes Mellitus, Type 2
Location: Stamford CT, The Bronx NY, Smithfield PA, Decatur GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT07668336
Phase 3, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue